THE IMPACT OF IL-17A THERAPY ON IGG SIALYLATION IN HUMANS

Pfeifle R, Kittler J, Wuhrer M, Schett G, Krönke G (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 1042-1043

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2021-eular.1087

Authors with CRIS profile

René Pfeifle Department of Medicine 3 – Rheumatology and Immunology Julia Kittler Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III Gerhard Krönke Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Leiden University

Netherlands (NL)

How to cite

APA:

Pfeifle, R., Kittler, J., Wuhrer, M., Schett, G., & Krönke, G. (2021). THE IMPACT OF IL-17A THERAPY ON IGG SIALYLATION IN HUMANS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1042-1043). LONDON: BMJ PUBLISHING GROUP.

MLA:

Pfeifle, René, et al. "THE IMPACT OF IL-17A THERAPY ON IGG SIALYLATION IN HUMANS." Proceedings of the Annual European Congress of Rheumatology (EULAR) LONDON: BMJ PUBLISHING GROUP, 2021. 1042-1043.

BibTeX: Download